NCT05698407View on ClinicalTrials.gov

Dexmedetomidine-Ropivacine Versus Sufentanil-Ropivacaine for Epidural Labor Analgesia

PHASE4CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

March 16, 2023

Primary Completion Date

June 15, 2023

Study Completion Date

August 28, 2023

Conditions
Pregnancy Related
Interventions
DRUG

Dexmedetomidine

loading dose of 0.45 microgram/ml dexmedetomidine plus 0.09% ropivacaine, maintenance dose of 0.36 microgram/ml dexmedetomidine plus 0.07% ropivacaine.

DRUG

Sufentanil

loading dose of 0.45 microgram/ml sufentanil plus 0.09% ropivacaine, maintenance dose of 0.36 microgram/ml sufentanil plus 0.07% ropivacaine.

Trial Locations (1)

100034

Peking University First Hospital, Beijin

All Listed Sponsors
lead

Peking University First Hospital

OTHER